World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Our website is made possible by displaying certain online content using javascript.
In order to view the full content, please disable your ad blocker or whitelist our website www.worldscientific.com.

System Upgrade on Mon, Jun 21st, 2021 at 1am (EDT)

During this period, the E-commerce and registration of new users may not be available for up to 6 hours.
For online purchase, please visit us again. Contact us at [email protected] for any enquiries.

Colorectal Cancer, Gut Microbiota and Traditional Chinese Medicine: A Systematic Review

    Based on the study and research on the pathogenesis of colorectal cancer, the types and functions of gut microbiota, and its role in guiding and regulating the occurrence and development of diseases, we have explored the mechanism of traditional Chinese medicine in the treatment of colorectal cancer by regulating the gut microbiota. Genetic variation, abnormal responses of innate and adaptive immunity, mucosal barrier dysfunction, imbalance of intestinal microbial colonization, personal and environmental risk factors are the main pathogenesis of colorectal cancer. The gut microbiota mainly includes Sclerotium (including Clostridium, Enterococcus, Lactobacillus and Ruminococcus) and Bacteroides (including Bacteroides and Prevotella), which have biological antagonism, nutrition for the organism, metabolic abilities, immune stimulation, and ability to shape cancer genes functions to body. The gut microbiota can be related to the health of the host. Current studies have shown that Chinese herbal compound, single medicinal materials, and monomer components can treat colorectal cancer by regulating the gut microbiota, such as Xiaoyaosan can increase the abundance of Bacteroides, Lactobacillus, and Proteus and decrease the abundance of Desulfovibrio and Rickerella. Therefore, studying the regulation and mechanism of gut microbiota on colorectal cancer is of great benefit to disease treatment.

    References

    • Abdulamir, A.S., R.R. Hafidh and F. Abu Bakar . The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role. J. Exp. Clin. Cancer Res. 30: 11, 2011. Crossref, Medline, ISIGoogle Scholar
    • Anfossi, S. and G.A. Calin . Gut microbiota: A new player in regulating immune- and chemo-therapy efficacy. Cancer Drug Resist. 3: 356–370, 2020. MedlineGoogle Scholar
    • Ansari, A., S. Bose, S.K. Lim, J.H. Wang, Y.H. Choi and H. Kim . Combination of Scutellaria baicalensis and metformin ameliorates diet-induced metabolic dysregulation in mice via the gut–liver–brain axis. Am. J. Chin. Med. 48: 1409–1433, 2020. Link, ISIGoogle Scholar
    • Aral, K., M.R. Milward, Y. Kapila, A. Berdeli and P.R. Cooper . Inflammasomes and their regulation in periodontal disease: A review. J. Periodontal Res. 55: 473–487, 2020. Crossref, Medline, ISIGoogle Scholar
    • Barrett, M., C.K. Hand, F. Shanahan, T. Murphy and P.W. O’Toole . Mutagenesis by microbe: The role of the microbiota in shaping the cancer genome. Trends Cancer 6: 277–287, 2020. Crossref, Medline, ISIGoogle Scholar
    • Boleij, A., E.M. Hechenbleikner, A.C. Goodwin, R. Badani, E.M. Stein, M.G. Lazarev, B. Ellis, K.C. Carroll, E. Albesiano, E.C. Wick, E.A. Platz, D.M. Pardoll and C.L. Sears . The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60: 208–215, 2015. Crossref, Medline, ISIGoogle Scholar
    • Burns, C.A., R. McCaughey and C.B. Lauter . The association of Streptococcus bovis fecal carriage and colon neoplasia: Possible relationship with polyps and their premalignant potential. Am. J. Gastroenterol. 80: 42–46, 1985. Medline, ISIGoogle Scholar
    • Chen, H.M., X.W. Liu, R.J. Sun and J.Y. Fang . A survey on the developmental intestinal microbiota research in China: The history, funding, and frontiers of gut bacteria. J. Dig. Dis. 16: 421–430, 2015. Crossref, Medline, ISIGoogle Scholar
    • Chen, L., M.S. Brar, F.C. Leung and W.L. Hsiao . Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice. Oncotarget 7: 31226–31242, 2016. Crossref, MedlineGoogle Scholar
    • Chen, L., M.Y. Chen, L. Shao, W. Zhang, T. Rao, H.H. Zhou and W.H. Huang . Panax notoginseng saponins prevent colitis-associated colorectal cancer development: The role of gut microbiota. Chin. J. Nat. Med. 18: 500–507, 2020a. Medline, ISIGoogle Scholar
    • Chen, H., F. Zhang, J. Zhang, X. Zhang, Y. Guo and Q. Yao . A holistic view of berberine inhibiting intestinal carcinogenesis in conventional mice based on microbiome–metabolomics analysis. Front Immunol. 11: 588079, 2020b. Crossref, Medline, ISIGoogle Scholar
    • Chen, L., B. Jiang, C. Zhong, J. Guo, L. Zhang, T. Mu, Q. Zhang and X. Bi . Chemoprevention of colorectal cancer by black raspberry anthocyanins involved the modulation of gut microbiota and SFRP2 demethylation. Carcinogenesis. 39: 471–481, 2018. Crossref, Medline, ISIGoogle Scholar
    • Cheng, Y., Z. Ling and L. Li . The intestinal microbiota and colorectal cancer. Front Immunol. 11: 615056, 2020. Crossref, Medline, ISIGoogle Scholar
    • Cheung, M.K., G.G.L. Yue, K.Y. Tsui, A.J. Gomes, H.S. Kwan, P.W.Y. Chiu and C.B.S. Lau . Discovery of an interplay between the gut microbiota and esophageal squamous cell carcinoma in mice. Am. J. Cancer Res. 10: 2409–2427, 2020. Medline, ISIGoogle Scholar
    • Choi, I.J., C.G. Kim, J.Y. Lee, Y.I. Kim, M.C. Kook, B. Park and J. Joo . Helicobacter pylori family history of gastric cancer and treatment. N. Engl. J. Med. 382: 427–436, 2020. Crossref, MedlineGoogle Scholar
    • Cong, J. and X. Zhang . Roles of intestinal microbiota in response to cancer immunotherapy. Eur. J. Clin. Microbiol. Infect. Dis. 37: 2235–2240, 2018. Crossref, Medline, ISIGoogle Scholar
    • Cueva, C., M. Silva, I. Pinillos, B. Bartolomé, and M.V. Moreno-Arribas . Interplay between dietary polyphenols and oral and gut microbiota in the development of colorectal cancer. Nutrients 12: 3, 2020. Crossref, ISIGoogle Scholar
    • Cui, G. , T9, T17, and T22 cell subsets and their main cytokine products in the pathogenesis of colorectal cancer. Front Oncol. 9: 1002, 2019. Crossref, Medline, ISIGoogle Scholar
    • Cui, G., A. Yuan, Z. Pang, W. Zheng, Z. Li and R. Goll . Contribution of IL-33 to the pathogenesis of colorectal cancer. Front Oncol. 8: 561, 2018. Crossref, Medline, ISIGoogle Scholar
    • Cui, X., Y. Jin, D. Poudyal, A.A. Chumanevich, T. Davis, A. Windust, A. Hofseth, W. Wu, J. Habiger, E. Pena, P. Wood, M. Nagarkatti, P.S. Nagarkatti, L. Hofseth . Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis. Carcinogenesis 31: 1734–1741, 2010. Crossref, Medline, ISIGoogle Scholar
    • Dahmus, J.D., D.L. Kotler, D.M. Kastenberg and Kistler CA . The gut microbiome and colorectal cancer: A review of bacterial pathogenesis. J. Gastrointest. Oncol. 9: 769–777, 2018. Crossref, Medline, ISIGoogle Scholar
    • Dai, C.E., H.L. Li, X.P. He, F.F. Zheng, H.L. Zhu, L.F. Liu and W. Du . Research advance in metabolism of effective ingredients from traditional Chinese medicines by probiotics. Zhongguo Zhong Yao Za Zhi. 43: 31–38, 2018. MedlineGoogle Scholar
    • De Almeida, C.V., M.R. de Camargo, E. Russo, A. Amedei . Role of diet and gut microbiota on colorectal cancer immunomodulation. World J. Gastroenterol. 25: 151–162, 2019. Crossref, Medline, ISIGoogle Scholar
    • De Martel, C. and S. Franceschi . Infections and cancer: Established associations and new hypotheses. Crit. Rev. Oncol. Hematol. 70: 183–194, 2009. Crossref, Medline, ISIGoogle Scholar
    • Ding, Q., B. Zhang, W. Zheng, X. Chen, J. Zhang, R. Yan, T. Zhang, L Yu, Y. Dong and B. Ma . Liupao tea extract alleviates diabetes mellitus and modulates gut microbiota in rats induced by streptozotocin and high-fat, high-sugar diet. Biomed. Pharmacother. 118: 109262, 2019. Crossref, Medline, ISIGoogle Scholar
    • Dong, L., L. Ma, G.H. Ma and H. Ren . Genome-wide analysis reveals DNA methylation alterations in obesity associated with high risk of colorectal cancer. Sci. Rep. 9: 5100, 2019. Crossref, Medline, ISIGoogle Scholar
    • Dougherty, U., R. Mustafi, Y. Wang, M.W. Musch, C.Z. Wang, V.J. Konda, A. Kulkarni, J. Hart, G. Dawson, K.E. Kim, C.S. Yuan, E.B. Chang and M. Bissonnette . American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: Role of EGFR. BMC Complement Altern. Med. 11: 111, 2011. Crossref, Medline, ISIGoogle Scholar
    • Feng, W., H. Ao, C. Pen and D. Yan . Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res. 142: 176–191, 2019. Crossref, Medline, ISIGoogle Scholar
    • Fessler, J., V. Matson and T.F. Gajewski . Exploring the emerging role of the microbiome in cancer immunotherapy. J. Immunother. Cancer 7: 108, 2019. Crossref, Medline, ISIGoogle Scholar
    • Frech, T.M., L. Fakoya, A.J. Gawron, J. Wong, M.B. Scholand, A. Sawitzke and K. Peterson . Oesophageal disease in systemic sclerosis: Does heritability play a role?. Clin. Exp. Rheumatol. 4: 86–88, 2017. Google Scholar
    • Gagnière, J., J. Raisch, J. Veziant, N. Barnich, R. Bonnet, E. Buc, M.A. Bringer, D. Pezet and M. Bonnet . Gut microbiota imbalance and colorectal cancer. World J. Gastroenterol. 22: 501–518, 2016. Crossref, Medline, ISIGoogle Scholar
    • Goel, A. and C.R. Boland . Epigenetics of colorectal cancer. Gastroenterology 143: 1442–1460, 2012. Crossref, Medline, ISIGoogle Scholar
    • Greabu, M., F. Giampieri, M.M. Imre, M. Mohora, A. Totan, S.M. Pituru and E. Ionescu . Autophagy, one of the main steps in periodontitis pathogenesis and evolution. Molecules 25: 4338, 2020. Crossref, ISIGoogle Scholar
    • Hao, S., Q. Fan, Y. Bai, H. Fang, J. Zhou, T. Fukuda, J. Gu, M. Li and W. Li . Salmonella core fucosylation of intestinal epithelial cells protects against typhi infection via up-regulating the biological antagonism of intestinal microbiota. Front Microbiol. 11: 1097, 2020. Crossref, Medline, ISIGoogle Scholar
    • Heiss, C.N. and L.E. Olofsson . The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system. J. Neuroendocrinol. 31: e12684, 2019. Crossref, Medline, ISIGoogle Scholar
    • Hold, G.L. and W.S. Garrett . Microbiota organization — a key to understanding CRC development. Nat. Rev. Gastroenterol. Hepatol. 12: 128–129, 2015. Crossref, Medline, ISIGoogle Scholar
    • Huang, G., I. Khan, X. Li, L. Chen, W. Leong, L.T. Ho and W.L.W. Hsiao . Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in Apc mice. Sci. Rep. 7: 12552, 2017. Crossref, Medline, ISIGoogle Scholar
    • Huang, Q., J. Wen, G. Chen, M. Ge, Y. Gao, X. Ye, C. Liu and C. Cai . Omega-3 polyunsaturated fatty acids inhibited tumor growth via preventing the decrease of genomic DNA methylation in colorectal cancer rats. Nutr. Cancer 68: 113–119, 2016. Crossref, Medline, ISIGoogle Scholar
    • Huang, X., X. Fan, J. Ying and S. Chen . Emerging trends and research foci in gastrointestinal microbiome. J. Transl. Med. 17: 67, 2019. Crossref, Medline, ISIGoogle Scholar
    • Jackson, D.N. and A.L. Theiss . Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Gut Microbes. 11: 285–304, 2020. Crossref, Medline, ISIGoogle Scholar
    • Jessurun, J., I. Cui and G. Aristi-Urista . Acute (gangrenous) esophageal necrosis (black esophagus). A rare form of injury with specific histologic features and diverse clinical associations with a common pathogenesis. Hum. Pathol. 87: 44–50, 2019. Crossref, Medline, ISIGoogle Scholar
    • Jiang, F., M. Liu, H. Wang, G. Shi, B. Chen, T. Chen, X. Yuan, P. Zhu, J. Zhou, Q. Wang and Y. Chen . Wu Mei Wan attenuates CAC by regulating gut microbiota and the NF-kB/IL6-STAT3 signaling pathway. Biomed. Pharmacother. 125: 109982, 2020. Crossref, Medline, ISIGoogle Scholar
    • Jing, Y., A. Li, Z. Liu, P. Yang, J. Wei, X. Chen, T. Zhao, Y. Bai, L. Zha and C. Zhang . Codonopsis pilosula absorption of saponins by coexisting polysaccharides alleviates gut microbial dysbiosis with dextran sulfate sodium-induced colitis in model mice. Biomed. Res. Int. 2018: 1781036, 2018. Crossref, Medline, ISIGoogle Scholar
    • Khan, I., G. Huang, X.A. Li, W. Liao, W.K. Leong, W. Xia, X. Bian, J. Wu and W.L.W. Hsiao . Mushroom polysaccharides and jiaogulan saponins exert cancer preventive effects by shaping the gut microbiota and microenvironment in Apc mice. Pharmacol. Res. 148: 104448, 2019. Crossref, Medline, ISIGoogle Scholar
    • King, M.L. and L.L. Murphy . Role of cyclin inhibitor protein p21 in the inhibition of HCT116 human colon cancer cell proliferation by American ginseng (Panax quinquefolius) and its constituents. Phytomedicine 17: 261–268, 2010. Crossref, Medline, ISIGoogle Scholar
    • Leystra, A.A. and M.L. Clapper . Gut microbiota influences experimental outcomes in mouse models of colorectal cancer. Genes (Basel) 10: 900, 2019. Crossref, ISIGoogle Scholar
    • Li, F., X.W. Yang, K.W. Krausz, R.G. Nichols, W. Xu, A.D. Patterson and F.J. Gonzalez . Modulation of colon cancer by nutmeg. J. Proteome Res. 14: 1937–1946, 2015. Crossref, Medline, ISIGoogle Scholar
    • Li, W., Y. Deng, Q. Chu and P. Zhang . Gut microbiome and cancer immunotherapy. Cancer Lett. 447: 41–47, 2019. Crossref, Medline, ISIGoogle Scholar
    • Li, Y., J. Shi, S. Qi, J. Zhang, D. Peng, Z. Chen, G. Wang, Z. Wang and L. Wang . IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE. J. Exp. Clin. Cancer Res. 37: 196, 2018. Crossref, Medline, ISIGoogle Scholar
    • Li, Y., S. Wang, Y. Sun, W. Xu, H. Zheng, Y. Wang, Y. Tang, X. Gao, C. Song, Y. Long, J. Liu, L. Liu and Q. Mei . Apple polysaccharide protects ICR mice against colitis associated colorectal cancer through the regulation of microbial dysbiosis. Carbohydr. Polym. 230: 115726, 2020. Crossref, Medline, ISIGoogle Scholar
    • Liao, W., I. Khan, G. Huang, S. Chen, L. Liu, W.K. Leong, X.A. Li, J. Wu and W.L. Wendy Hsiao . Bifidobacterium animalis: The missing link for the cancer-preventive effect of Gynostemma pentaphyllum. Gut Microbes 24: 1–14, 2020. CrossrefGoogle Scholar
    • Liu, H., Y. Qin, K. Li, M. Li, J. Yang, H. Tao, Y. Tang, L. Yang, S. Chen, Y. Liu, C. Yang, W Gao and T. Sun . Potential T2DM drug HMPA promotes short-chain fatty acid production by improving carbon catabolite repression effect of gut microbiota. Br. J. Pharmacol. 178: 946–963, 2021. Crossref, Medline, ISIGoogle Scholar
    • Liu, X., Y. Cheng, L. Shao and Z. Ling . Alterations of the predominant fecal microbiota and disruption of the gut mucosal barrier in patients with early-stage colorectal cancer. Biomed. Res. Int. 2020: 2948282, 2020. Medline, ISIGoogle Scholar
    • Lv, J., Y. Jia, J. Li, W. Kuai, Y. Li, F. Guo, X. Xu, Z. Zhao, J. Lv and Z. Li . Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodeling the gut microbiota and the tumor microenvironment. Cell Death Dis. 10: 415, 2019. Crossref, Medline, ISIGoogle Scholar
    • Man, S.M. , Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat. Rev. Gastroenterol. Hepatol. 15: 721–737, 2018. Crossref, Medline, ISIGoogle Scholar
    • Maresch, C.C., D.C. Stute, T. Fleming, J. Lin, H.P. Hammes and T. Linn . Hyperglycemia induces spermatogenic disruption via major pathways of diabetes pathogenesis. Sci. Rep. 9: 13074, 2019. Crossref, Medline, ISIGoogle Scholar
    • Murphy, N., V. Moreno, D.J. Hughes, L. Vodicka, P. Vodicka, E.K. Aglago, M.J. Gunter and M. Jenab . Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Mol. Aspects Med. 69: 2–9, 2019. Crossref, Medline, ISIGoogle Scholar
    • Niu, D., S. An, X. Chen, H. Bi, Q. Zhang, T. Wang, B. Han, H. Zhang and J. Kang . Corni Fructus as a natural resource can treat type 2 diabetes by regulating gut microbiota. Am. J. Chin. Med. 48: 1385–1407, 2020. Link, ISIGoogle Scholar
    • Pastille, E., M.H. Wasmer, A. Adamczyk, V.P. Vu, L.F. Mager, N.N.T. Phuong, V. Palmieri, C. Simillion, W. Hansen, S. Kasper, M. Schuler, B. Muggli, K.D. McCoy, J. Buer, I. Zlobec, A.M. Westendorf and P. Krebs . The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Mucosal Immunol. 12: 990–1003, 2019. Crossref, Medline, ISIGoogle Scholar
    • Peng, M., S.H. Lee, S.O. Rahaman and D. Biswas . Dietary probiotic and metabolites improve intestinal homeostasis and prevent colorectal cancer. Food Funct. 11: 10724–10735, 2020. Crossref, Medline, ISIGoogle Scholar
    • Pluta, R., S. Januszewski and M Ułamek-Kozioł . Mutual two-way interactions of curcumin and gut microbiota. Int. J. Mol. Sci. 21: 1055, 2020. Crossref, ISIGoogle Scholar
    • Poudyal, D., P.M. Le, T. Davis, A.B. Hofseth, A. Chumanevich, A.A. Chumanevich, M.J. Wargovich, M. Nagarkatti, P.S. Nagarkatti, A. Windust and L.J. Hofseth . A hexane fraction of American ginseng suppresses mouse colitis and associated colon cancer: Anti-inflammatory and proapoptotic mechanisms. Cancer Prev. Res. (Phila.) 5: 685–696, 2012. Crossref, Medline, ISIGoogle Scholar
    • Razi, S., B. Baradaran, Noveiry, M. Keshavarz-Fathi and N. Rezaei . IL-17 and colorectal cancer: From carcinogenesis to treatment. Cytokine 116: 7–12, 2019. Crossref, Medline, ISIGoogle Scholar
    • Reis, S.A.D., L.L. da, Conceição and M.D.C.G. Peluzio . Intestinal microbiota and colorectal cancer: changes in the intestinal microenvironment and their relation to the disease. J. Med. Microbiol. 68: 1391–1407, 2019. Crossref, Medline, ISIGoogle Scholar
    • Rinninella, E., P. Raoul, M. Cintoni, F. Franceschi, G.A.D. Miggiano, A. Gasbarrini, M.C. Mele . What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7: 14, 2019. Crossref, ISIGoogle Scholar
    • Rubinstein, M.R., X. Wang, W. Liu, Y. Hao, G. Cai and Y.W. Han . Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14: 195–206, 2013. Crossref, Medline, ISIGoogle Scholar
    • Saus, E., S. Iraola-Guzmán, J.R. Willis, A. Brunet-Vega and T. Gabaldón . Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential. Mol. Aspects Med. 69: 93–106, 2019. Crossref, Medline, ISIGoogle Scholar
    • Shao, D.Y., X. Bai, M.W. Tong, Y.Y. Zhang, X.L. Liu, Y.H. Zhou, C. Li, W. Cai, X. Gao, M. Liu and Y. Yang . Changes to the gut microbiota in mice induced by infection with Toxoplasma gondii. Acta Trop. 203: 105301, 2020. Crossref, Medline, ISIGoogle Scholar
    • Shen, C., T. Yan, Z. Wang, H.C. Su, X. Zhu, X. Tian, J.Y. Fang, H. Chen and J. Hong . Variant of SNP rs1317082 at CCSlnc362 (RP11-362K14.5) creates a binding site for miR-4658 and diminishes the susceptibility to CRC. Cell Death Dis. 9: 1177, 2018. Crossref, Medline, ISIGoogle Scholar
    • Sherwood, A.M., R.O. Emerson, D. Scherer, N. Habermann, K. Buck, J. Staffa, C. Desmarais, N. Halama, D. Jaeger, P. Schirmacher, E. Herpel, M. Kloor, A. Ulrich, M. Schneider, C.M. Ulrich and H. Robins . Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue. Cancer Immunol. Immunother. 62: 1453–1461, 2013. Crossref, Medline, ISIGoogle Scholar
    • Si, H., Q. Yang, H. Hu, C. Ding, H. Wang and X. Lin . Colorectal cancer occurrence and treatment based on changes in intestinal flora. Semin. Cancer Biol. 11: S1044-579X(20)30100-0, 2020. Google Scholar
    • Singh, M.P., S. Rai, S. Suyal, S.K. Singh, N.K. Singh, A. Agarwal and S. Srivastava . Genetic and epigenetic markers in colorectal cancer screening: Recent advances. Expert Rev. Mol. Diagn. 17: 665–685, 2017. Crossref, Medline, ISIGoogle Scholar
    • Stanisic, D., M. Jovanovic, A.K. George, R.P. Homme, N. Tyagi, M. Singh and S.C. Tyagi . Gut microbiota and the periodontal disease: Role of hyperhomocysteinemia. Can. J. Physiol. Pharmacol. 99: 9–17, 2021. Crossref, Medline, ISIGoogle Scholar
    • Sugimoto, S., M. Naganuma and T. Kanai . Indole compounds may be promising medicines for ulcerative colitis. J. Gastroenterol. 51: 853–861, 2016. Crossref, Medline, ISIGoogle Scholar
    • Sui, H., L. Zhang, K. Gu, N. Chai, Q. Ji, L. Zhou, Y. Wang, J. Ren, L. Yang, B. Zhang, J. Hu and Q. Li . YYFZBJS ameliorates colorectal cancer progression in Apc mice by remodeling gut microbiota and inhibiting regulatory T-cell generation. Cell Commun. Signal. 18: 113, 2020. Crossref, Medline, ISIGoogle Scholar
    • Sun, L., Y. Yan, D. Chen and Y. Yang . Quxie capsule modulating gut microbiome and its association with T cell regulation in patients with metastatic colorectal cancer: Result from a randomized controlled clinical trial. Integr. Cancer Ther. 19: 1534735420969820, 2020. Crossref, ISIGoogle Scholar
    • Takasu, C., M. Nishi, K. Yoshikawa, T. Tokunaga, H. Kashihara, T. Yoshimot and M. Shimada . Impact of sidedness of colorectal cancer on tumor immunity. PLoS One 15: 0240408, 2020. Crossref, ISIGoogle Scholar
    • Villéger, R., A. Lopès, J. Veziant, J. Gagnière, N. Barnich, E. Billard, D. Boucher and M. Bonnet . Microbial markers in colorectal cancer detection and/or prognosis. World J. Gastroenterol. 24: 2327–2347, 2018. Crossref, Medline, ISIGoogle Scholar
    • Wang, C.Z., W.H. Huang, C.F. Zhang, J.Y. Wan, Y. Wang, C. Yu, S. Williams, T.C. He, W. Du, M.W. Musch, E.B. Chang and C.S. Yuan . Role of intestinal microbiome in American ginseng-mediated colon cancer prevention in high fat diet-fed AOM/DSS mice. Clin. Transl. Oncol. 20: 302–312, 2018. Crossref, Medline, ISIGoogle Scholar
    • Wang, C.Z., C. Yu, X.D. Wen, L. Chen, C.F. Zhang, T. Calway, Y. Qiu, Y. Wang, Z. Zhang, S. Anderson, Y. Wang, W. Jia, C.S. Yuan . American ginseng attenuates colitis-associated colon carcinogenesis in mice: Impact on gut microbiota and metabolomics. Cancer Prev. Res (Phila.) 9: 803–811, 2016. Crossref, Medline, ISIGoogle Scholar
    • Wang, C.Z., C.F. Zhang, L. Chen, S. Anderson, F. Lu and C.S. Yuan . Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalin. Int. J. Oncol. 47: 1749–1758, 2015. Crossref, Medline, ISIGoogle Scholar
    • Wang, C.Z., C.F. Zhang, Y. Luo, H. Yao, C. Yu, L. Chen, J. Yuan, W.H. Huang, J.Y. Wan, J. Zeng, W.R. Sawadogo and C.S. Yuan . Baicalein, an enteric microbial metabolite, suppresses gut inflammation and cancer progression in Apc mice. Clin. Transl. Oncol. 22: 1013–1022, 2020. Crossref, Medline, ISIGoogle Scholar
    • Wang, T., G. Cai, Y. Qiu, N. Fei, M. Zhang, X. Pang, W. Jia, S. Cai and L. Zhao . Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6: 320–329, 2012. Crossref, Medline, ISIGoogle Scholar
    • Wang, Y., S. Qin, J. Jia, L. Huang, F. Li, F. Jin, Z. Ren and Y. Wang . Intestinal microbiota-associated metabolites: Crucial factors in the effectiveness of herbal medicines and diet therapies. Front Physiol. 10: 1343, 2019. Crossref, Medline, ISIGoogle Scholar
    • Weng, W. and A. Goel . Curcumin and colorectal cancer: An update and current perspective on this natural medicine. Semin. Cancer Biol. 2020. CrossrefGoogle Scholar
    • Wu, Y., D. Wang, X. Yang, C. Fu, L. Zou and J. Zhang . Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice. Biomed. Pharmacother. 109: 2252–2261, 2019. Crossref, Medline, ISIGoogle Scholar
    • Yang, Z.H., Y.Q. Dang and G. Ji . Role of epigenetics in transformation of inflammation into colorectal cancer. World. J. Gastroenterol. 25: 2863–2877, 2019. Crossref, Medline, ISIGoogle Scholar
    • Yao, H., J.Y. Wan, J. Zeng, W.H. Huang, C. Sava-Segal, L. Li, X. Niu, Q. Wang, C.Z. Wang and C.S. Yuan . Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer. Oncol. Lett. 15: 8339–8348, 2018. Medline, ISIGoogle Scholar
    • Yu, L.C. , Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: Exploring a common ground hypothesis. J. Biomed. Sci. 25: 79, 2018. Crossref, Medline, ISIGoogle Scholar
    • Yu, L., Z.K. Xing, S.L. Mi and X. Wu . Regulatory effect of traditional Chinese medicine on intestinal microbiota. Zhongguo Zhong Yao Za Zhi. 44: 34–39, 2019. MedlineGoogle Scholar
    • Zaher, S. , Nutrition and the gut microbiome during critical illness: A new insight of nutritional therapy. Saudi J. Gastroenterol. 2020. Crossref, Medline, ISIGoogle Scholar
    • Zeng, Y.X., S. Wang, L. Wei, Y.Y. Cui and Y.H. Chen . Proanthocyanidins: Components, pharmacokinetics and biomedical properties. Am. J. Chin. Med. 48: 813–869, 2020. Link, ISIGoogle Scholar
    • Zhang, H., D. Hui, Y. Li, G. Xiong and X. Fu . Canmei formula reduces colitis-associated colorectal carcinogenesis in mice by modulating the composition of gut microbiota. Front. Oncol. 9: 1149, 2019. Crossref, Medline, ISIGoogle Scholar
    • Zhang, X., S. Zhao, X. Song, J. Jia, Z. Zhang, H. Zhou, H. Fu, H. Cui, S. Hu, M. Fang, X. Liu, Y. Bian . Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition. J. Pharmacol. Sci. 137: 324–332, 2018. Crossref, Medline, ISIGoogle Scholar
    • Zhang, Z., S. Shao, Y. Zhang, R. Jia, X. Hu, H. Liu, M. Sun, B. Zhang, Q. Li and Y. Wang . Xiaoyaosan slows cancer progression and ameliorates gut dysbiosis in mice with chronic restraint stress and colorectal cancer xenografts. Biomed. Pharmacother. 132: 110916, 2020. Crossref, Medline, ISIGoogle Scholar
    • Zhang, Z., X. Wu, S. Cao, M. Cromie, Y. Shen, Y. Feng, H. Yang and L. Li . Chlorogenic acid ameliorates experimental colitis by promoting growth of Akkermansia in mice. Nutrients 9: 677, 2017. Crossref, ISIGoogle Scholar
    • Zhu, L., J. Han, L. Li, Y. Wang, Y. Li and S. Zhang . Claudin family participates in the pathogenesis of inflammatory bowel diseases and colitis-associated colorectal cancer. Front. Immunol. 10: 1441, 2019a. Crossref, Medline, ISIGoogle Scholar
    • Zhu, W., N. Miyata, M.G. Winter, A. Arenales, E.R. Hughes, L. Spiga, J. Kim, L. Sifuentes-Dominguez, P. Starokadomskyy, P. Gopal, M.X. Byndloss, R.L. Santos, E. Burstein and S.E. Winter . Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer. J. Exp. Med. 216: 2378–2393, 2019b. Crossref, Medline, ISIGoogle Scholar
    • Zhu, L.Q., L. Zhang, J. Zhang, G.L. Chang, G. Liu, D.D. Yu, X.M. Yu, M.S. Zhao and B. Ye . Evodiamine inhibits high-fat diet-induced colitis-associated cancer in mice through regulating the gut microbiota. J. Integr. Med. 19: 56–65, 2021. Crossref, MedlineGoogle Scholar
    Published: 6 April 2021
    Remember to check out the Most Cited Articles!

    Check out our Chinese Medicine Titles today.
    Includes titles by Nobel Winner, Tu You You and more!